Related Experiment Videos
[Validation and comparison of pharmacogenetics-based warfarin dosing algorithms in Han Chinese patients]
Liang-ping Yu1, Hong-tao Song, Zhi-yong Zeng
1Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China.
Insights
Pharmacogenetics-based warfarin dosing algorithms were evaluated in Han Chinese patients with mechanical heart valves. The Wen model best predicted warfarin doses, while the Ohno model showed superior clinical accuracy for dose adjustments.
Area of Science:
- Pharmacogenomics
- Cardiovascular Surgery
- Internal Medicine
Background:
- Warfarin dosing requires careful management, especially in patients with mechanical heart valves.
- Genetic factors, including CYP2C9 and VKORC1 polymorphisms, significantly influence warfarin metabolism and response.
- Existing pharmacogenetic algorithms aim to personalize warfarin dosing but require validation in diverse populations.
Purpose of the Study:
- To evaluate the predictive accuracy of three established pharmacogenetics-based warfarin dosing algorithms.
- To determine the most suitable algorithm for estimating the maintenance warfarin dose in Han Chinese patients who have undergone mechanical heart valve replacement.
Main Methods:
- Genotyping for CYP2C9 and VKORC1 polymorphisms using PCR-RFLP in 130 Han Chinese patients.
- Calculation of predicted warfarin doses using the IWPC, Ohno, and Wen algorithms.
- Assessment of prediction accuracy using absolute and percentage differences, R-squared values, and clinical dosing categories (under-, ideally-, and over-dosed).
Main Results:
- The Wen model demonstrated the lowest average absolute error (3.74 mg/wk) and highest R-squared (40.2%).
- The Wen model achieved the best prediction accuracy in the low-dose group (50.0% ideally dosed).
- The Ohno model showed the highest clinical accuracy in the middle-dose group (85.29% ideally dosed).
Conclusions:
- The Wen algorithm provides the best overall accuracy for predicting maintenance warfarin doses in this patient cohort.
- The Ohno algorithm offers superior clinical accuracy for dose adjustments in the middle-dose range.
- Algorithm selection may depend on the specific accuracy metric and patient dosing group considered.
Objective:
To assess whether the existing three types of pharmacogenetics-based Warfarin dosing algorithms appropriately predict the actual maintenance dose in Han Chinese mechanical heart valve replacement patients (n = 130).
Methods:
The patients' CYP2C9 and VKORC1 genetic polymorphisms were detected by PCR-RFLP. The genotype of CYP2C9, VKORC1 and other information were used to calculate predicted doses. Accuracy of the models was assessed using the absolute value of the difference between predicted dose and actual dose, calculated on both an absolute and percentage basis. Actual weekly dose was also regressed on predicted weekly dose, from which we obtained R(2) values. Clinical accuracy of the predictions was assessed by computing the proportion in which the predicted dose was 20% or more below the actual dose (under dosed), within 20% of the actual dose (ideally dosed), or 20% or greater above the actual dose (over dosed).
Results:
The average absolute error is the smallest for the predictions made by the Wen model (3.74 mg/wk), followed by the Ohno model (4.07 mg/wk) and IWPC model (5.05 mg/wk). R(2) was 40.2% in the Wen model, 38.2% in the Ohno model and 26.7% in the IWPC model. When comparing the percentage of patients for whom the predicted doses were ideal, the Wen model works the best (50.0%) in low-dose group (≤ 21 mg/wk), but the Ohno model works the best (85.29%) in middle-dose group (21 - 49 mg/wk), followed by the Wen model.
Conclusion:
The best accuracy is achieved by the Wen model and the best clinical accuracy is obtained by the Ohno model for predicting the actual maintenance dose in Han Chinese mechanical heart valve replacement patients.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Metabolism: Overview
Drug Dosing: Geriatric Patients
Therapeutic Drug Monitoring: Affecting Factors
Principles of Pharmacogenetics: Types of Genetic Variants
Drug toxicity: Idiosyncratic Reactions